Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

319 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Impact of tafamidis on myocardial strain in transthyretin amyloid cardiomyopathy.
Rettl R, Duca F, Binder C, Dachs TM, Cherouny B, Camuz Ligios L, Mann C, Schrutka L, Dalos D, Charwat-Resl S, Badr Eslam R, Kastner J, Bonderman D. Rettl R, et al. Among authors: kastner j. Amyloid. 2023 Mar;30(1):127-137. doi: 10.1080/13506129.2022.2131385. Epub 2022 Oct 17. Amyloid. 2023. PMID: 36251806
Tafamidis treatment delays structural and functional changes of the left ventricle in patients with transthyretin amyloid cardiomyopathy.
Rettl R, Mann C, Duca F, Dachs TM, Binder C, Ligios LC, Schrutka L, Dalos D, Koschutnik M, Donà C, Kammerlander A, Beitzke D, Loewe C, Charwat-Resl S, Hengstenberg C, Kastner J, Eslam RB, Bonderman D. Rettl R, et al. Among authors: kastner j. Eur Heart J Cardiovasc Imaging. 2022 Jun 1;23(6):767-780. doi: 10.1093/ehjci/jeab226. Eur Heart J Cardiovasc Imaging. 2022. PMID: 34788394
Impact of Tafamidis and Optimal Background Treatment on Physical Performance in Patients With Transthyretin Amyloid Cardiomyopathy.
Badr Eslam R, Öztürk B, Rettl R, Capelle CDJ, Qin H, Binder C, Dachs TM, Camuz Ligios L, Duca F, Dalos D, Schrutka L, Alasti F, Kastner J, Vila G, Bonderman D. Badr Eslam R, et al. Among authors: kastner j. Circ Heart Fail. 2022 Jul;15(7):e008381. doi: 10.1161/CIRCHEARTFAILURE.121.008381. Epub 2022 Jun 29. Circ Heart Fail. 2022. PMID: 35766028
Machine learning-derived electrocardiographic algorithm for the detection of cardiac amyloidosis.
Schrutka L, Anner P, Agibetov A, Seirer B, Dusik F, Rettl R, Duca F, Dalos D, Dachs TM, Binder C, Badr-Eslam R, Kastner J, Beitzke D, Loewe C, Hengstenberg C, Laufer G, Stix G, Dorffner G, Bonderman D. Schrutka L, et al. Among authors: kastner j. Heart. 2022 Jun 24;108(14):1137-1147. doi: 10.1136/heartjnl-2021-319846. Heart. 2022. PMID: 34716183 Free PMC article.
What Type of Patients Did PARAGON-HF Select? Insights from a Real-World Prospective Cohort of Patients with Heart Failure and Preserved Ejection Fraction.
Rettl R, Dachs TM, Duca F, Binder C, Dusik F, Seirer B, Schönauer J, Kronberger C, Camuz Ligios L, Hengstenberg C, Derkits N, Kastner J, Badr Eslam R, Bonderman D. Rettl R, et al. Among authors: kastner j. J Clin Med. 2020 Nov 15;9(11):3669. doi: 10.3390/jcm9113669. J Clin Med. 2020. PMID: 33203151 Free PMC article.
Convolutional Neural Networks for Fully Automated Diagnosis of Cardiac Amyloidosis by Cardiac Magnetic Resonance Imaging.
Agibetov A, Kammerlander A, Duca F, Nitsche C, Koschutnik M, Donà C, Dachs TM, Rettl R, Stria A, Schrutka L, Binder C, Kastner J, Agis H, Kain R, Auer-Grumbach M, Samwald M, Hengstenberg C, Dorffner G, Mascherbauer J, Bonderman D. Agibetov A, et al. Among authors: kastner j. J Pers Med. 2021 Dec 1;11(12):1268. doi: 10.3390/jpm11121268. J Pers Med. 2021. PMID: 34945740 Free PMC article.
Riociguat in pulmonary hypertension and heart failure with preserved ejection fraction: the haemoDYNAMIC trial.
Dachs TM, Duca F, Rettl R, Binder-Rodriguez C, Dalos D, Ligios LC, Kammerlander A, Grünig E, Pretsch I, Steringer-Mascherbauer R, Ablasser K, Wargenau M, Mascherbauer J, Lang IM, Hengstenberg C, Badr-Eslam R, Kastner J, Bonderman D. Dachs TM, et al. Among authors: kastner j. Eur Heart J. 2022 Sep 21;43(36):3402-3413. doi: 10.1093/eurheartj/ehac389. Eur Heart J. 2022. PMID: 35909264 Free PMC article. Clinical Trial.
Reperfusion therapies and in-hospital outcomes for ST-elevation myocardial infarction in Europe: the ACVC-EAPCI EORP STEMI Registry of the European Society of Cardiology.
Zeymer U, Ludman P, Danchin N, Kala P, Laroche C, Sadeghi M, Caporale R, Shaheen SM, Legutko J, Iakobsishvili Z, Alhabib KF, Motovska Z, Studencan M, Mimoso J, Becker D, Alexopoulos D, Kereseselidze Z, Stojkovic S, Zelveian P, Goda A, Mirrakhimov E, Bajraktari G, Al-Farhan H, Šerpytis P, Raungaard B, Marandi T, Moore AM, Quinn M, Karjalainen PP, Tatu-Chitolu G, Gale CP, Maggioni AP, Weidinger F; ACVC EAPCI EORP ACS STEMI investigators group of the ESC. Zeymer U, et al. Eur Heart J. 2021 Nov 21;42(44):4536-4549. doi: 10.1093/eurheartj/ehab342. Eur Heart J. 2021. PMID: 34389857
319 results